Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Stock market today: The Nifty 50 index has a support at 23,400 mark, and the 50-stock index faces a resistance at 23,700 ...

Biocon is a prominent global biopharmaceutical company driven by innovation, specialising in therapies for chronic conditions ...

Mayuresh Joshi, Head Equity, Marketsmith India, shared his insights on the performance of various companies. He noted that ...

The rise in Sobha share price came on the back of stellar show in the September quarter of financial year 2025 (Q2FY25) ...

I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...

The construction of the overpass at Nanthoor junction in the city was progressing at a good pace. However, the entire process ...

Biocon Academy announced a 100% placement success for Batch 6 of the Biocon Ramaiah Certificate Programme in Quality Control Analytical, achieved in a record 2.5 hours. The placement drive attracted ...

Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: ...

Demand and pricing challenges, and a scheduled facility shutdown hit quarterly numbers. Biocon entered into exclusive licensing agreements with two leading pharmaceutical companies in the Middle ...

IST, the barometer index, the S&P BSE Sensex declined 211.60 points or 0.29% to 77,366.38. The Nifty 50 index lost 63.50 points or 0.27% to 23,469.20.

The 17th CPHI and PMEC India Expo in Greater Noida highlights pharma modernization and sustainability, hosting over 2,000 ...